You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KPTI Sale Disclosure
Abate Kristin · SEC Form 4 · Filed Oct 2, 2026
Sale
Calculated transaction value
$449.82
Abate Kristin Chief Accounting Officer
KPTI
Transaction date
Oct 1, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 1 day later
KPTI daily price context
Close on/before transaction
$0.87
Oct 1, 2026
First close after public filing
$0.67
Oct 5, 2026
30-day return after filing
-83.3%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 378 shares @ $1.19
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-412209
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$449.82
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Karyopharm Therapeutics Inc. KPTI Current | Sale | Oct 1, 2026 | $449.82 |